AlbuminuriaDiabetic NephropathiesGlomerular Filtration RatePodocytesKidney GlomerulusCreatinineDiabetes Mellitus, Type 2Kidney DiseasesKidneyGlutamyl AminopeptidaseProteinuriaBlood PressureRenal InsufficiencyRenal Insufficiency, ChronicKidney Function TestsGlomerulosclerosis, Focal SegmentalRisk FactorsHypertensionGlomerular Filtration BarrierDiabetes Mellitus, ExperimentalHypertension, RenalAlbuminsDiabetes Mellitus, Type 1Kidney Failure, ChronicCross-Sectional StudiesLosartanIndians, North AmericanDisease ProgressionCardiovascular DiseasesBiological MarkersAntihypertensive AgentsGlomerulonephritisAngiotensin-Converting Enzyme InhibitorsPrevalenceCollagen Type IVAngiotensin II Type 1 Receptor BlockersDiabetic AngiopathiesFumaratesCystatin CDiabetes ComplicationsHemoglobin A, GlycosylatedNorthern TerritoryUrinalysisNephritisCohort StudiesOceanic Ancestry GroupEnalaprilNephrosisDisease Models, AnimalDiabetes MellitusNorth DakotaProspective StudiesNephrectomyFollow-Up StudiesTetrazolesAutomobile Driver ExaminationGlomerular MesangiumChronic DiseaseRenin-Angiotensin SystemRats, TransgenicStreptozocinSouth DakotaMesangial CellsAnimals, CongenicNephrotic SyndromeIncidenceGlycosuriaAminopeptidasesRamiprilBasement MembraneAntigens, Thy-1Biphenyl CompoundsUnited StatesPuromycin Aminonucleoside